knowledge -WSS

knowledge

author：explore 2025-09-28 09:17:20 - browse：3624

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： All of Us, NIH's precision medicine initiative, gets a big boost

WSS

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

The health care issue Democrats can’t solve: hospital reform

Biden calls for immediate release of Niger's president amid apparent coup

Coloradans with cystic fibrosis could lose access to Trikafta

Travis Kelce and the trap of celebrity vaccine endorsements

Wikipedia

knowledge

explore

Psychedelics group wrestles with new pharma identity

Medicare must police algorithms in Medicare Advantage, Dems say

United colonoscopy coverage change 'may cost lives,' doctors say

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Medical records are filled with copy

Explaining an after

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What Mike Pence has said that could be used in a Donald Trump trial

Medical records are filled with copy

All of Us, NIH's precision medicine initiative, gets a big boost

explore

Attacks on the drug industry will lead to fewer breakthroughs

2 US Navy sailors arrested for allegedly spying for China

How neuroscience research could help beat back brain cancer

What is microchimerism and how does it affect maternal health?

Gene therapy’s promise and the high cost of hope

2 US Navy sailors arrested for allegedly spying for China

Wikipedia

knowledge

focus

hotspot